Bovie Medical Co. (NYSE:BVX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.
According to Zacks, “Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devices and advanced coating technologies. “
Separately, JMP Securities reissued an “outperform” rating and set a $5.00 price target on shares of Bovie Medical in a research note on Wednesday, August 3rd.
Shares of Bovie Medical (NYSE:BVX) traded down 3.64% on Tuesday, reaching $5.30. The company had a trading volume of 282,253 shares. The firm has a 50-day moving average price of $4.26 and a 200 day moving average price of $2.46. The firm’s market capitalization is $143.37 million. Bovie Medical has a 1-year low of $1.56 and a 1-year high of $5.69.
In other news, insider John J. Mccarthy III purchased 90,750 shares of the firm’s stock in a transaction dated Wednesday, August 17th. The shares were acquired at an average price of $3.30 per share, with a total value of $299,475.00. Following the purchase, the insider now directly owns 115,750 shares of the company’s stock, valued at $381,975. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.
An institutional investor recently raised its position in Bovie Medical stock. BlackRock Fund Advisors boosted its stake in Bovie Medical Co. (NYSE:BVX) by 27.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,051 shares of the medical device company’s stock after buying an additional 15,305 shares during the period. BlackRock Fund Advisors owned about 0.27% of Bovie Medical worth $118,000 at the end of the most recent quarter.
Bovie Medical Company Profile
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Bovie Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical Co. and related companies with MarketBeat.com's FREE daily email newsletter.